Results 31 to 40 of about 409,422 (240)
World Journal of Surgical Oncology, 2009 Background Malignant Mesothelioma is a rare primary neoplasm affecting the serosal membranes. During its relative short course, this malignant neoplasm can give local and, rarely, distant haematogenous metastases in different organs.
Lawrence Julia +3 more
doaj +1 more source
Insights into Imaging, 2021 The peritoneal cavity is the second commonest site of mesothelioma after the pleural cavity. There are five histological types of peritoneal mesothelioma with variable symptomatology, clinical presentation and prognosis.
Anuradha Chandramohan +6 more
doaj +1 more source
Mesothelioma in South Africa 3 decades post peak of asbestos production an analysis of a claims database of asbestos ex-miners [PDF]
, 2012 Includes bibliographical references.The peak in production of the three forms of asbestos that were commercially mined in South Africa occurred in the years between 1970 and 1977.
Mothemela, Mokgadi
core +1 more source
Massive Pleural Effusion Leads to the Revelation of Malignant Pleural Mesothelioma: A Case Report
Jurnal RespirasiIntroduction: Malignant mesothelioma is a cancer that develops from the thin layer of tissue covering visceral organs (mesothelium). Up to 80% of malignant mesothelioma cases are caused by asbestos exposure.
Gede Adi Prasetya Wijaya +3 more
doaj +1 more source
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
European Respiratory Review, 2016 Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the ...
Anna C. Bibby +7 more
doaj +1 more source
Advanced Science, EarlyView.Proposed molecular mechanism: NSUN6 catalyzes m5C methylation on Snail mRNA to enhance its stability, leading to Snail upregulation and EMT promotion. The first‐in‐class inhibitor AL398 suppresses endometrial cancer metastasis by targeting the NSUN6‐m5C‐Snail. axis. ABSTRACT Endometrial cancer (EC) constitutes a leading gynecologic malignancy for which
Xiangzhuan Zhao +19 more
wiley +1 more source
Anti-Tumor Effects of TRAIL-Expressing Mesenchymal Stromal Cells in a Mouse Xenograft Model of Human Mesothelioma [PDF]
, 2015 Malignant mesothelioma (MM) remains a highly deadly malignancy with poor treatment option. The MM cells further promote a highly inflammatory microenvironment which contributes to tumor initiation, development, severity, and propagation. We reasoned that
Sage, E, Janes, SM
core
Management of Malignant Pleural Mesothelioma
, 2019 Malignant mesothelioma (MM) arises from mesothelial surfaces of the pleural cavity, peritoneal cavity, tunica vaginalis, or pericardium. MM is a rare and insidious neoplasm with a poor prognosis.
Güngör Utkan, Mustafa Gürbüz
core +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
British Journal of Clinical Pharmacology, EarlyView.CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
F1000Research, 2018 Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US. Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for ...
Waqas Amin +4 more
doaj +1 more source